Free Trial
→ $4,200 gold is nice ... but here’s what most gold bugs are missing (From Weiss Ratings) (Ad)tc pixel

Lu Li Analyst Performance

Analyst at UBS Group

Lu Li is a stock analyst at UBS Group in the medical sector, covering 3 publicly traded companies. Over the past year, Lu Li has issued 4 stock ratings, including buy and hold recommendations. While full access to Lu Li's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Lu Li's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Analyst Ranking
Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
4 Last 0 Years
Buy Recommendations
50.00% 2 Buy Ratings
Companies Covered
3 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy50.0%2 ratings
Hold50.0%2 ratings
Sell0.0%0 ratings

Out of 4 total stock ratings issued by Lu Li at UBS Group, the majority (50.0%) have been Buy recommendations, followed by 50.0% Hold.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
3 companies

Lu Li, an analyst at UBS Group, currently covers 3 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
3 companies		100.0%

Lu Li of UBS Group specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MED PRODUCTS
1 company		33.3%
MEDICAL INFO SYS
1 company		33.3%
MED INSTRUMENTS
1 company		33.3%

Lu Li's Ratings History at UBS Group

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
Export to Excel
CompanyReport DateActionReport Date Price12-Month
Price Target		Rating12-Month
Price & ROI		Details
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
8/7/2025Lower Price Target$23.95$26.00Neutral
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
8/5/2025Upgrade$18.36$30.00Buy
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
5/8/2025Lower Price Target$36.59$29.00Neutral
Veracyte, Inc. stock logo
VCYT
Veracyte
5/8/2025Lower Price Target$31.51$42.00Buy
Today's Ratings
Top-Rated Stocks
More Ratings Tools